Literature DB >> 17189982

Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma.

Bozo Kruslin1, Davor Tomas, Aida Cviko, Hrvoje Cupic, Ljubica Odak, Mladen Belicza.   

Abstract

The aim of the present study was to correlate the presence and extent of retraction clefting and the expression of p63 in neoplastic glands and glands with prostatic intraepithelial neoplasia (PIN) in needle core biopsies. We analyzed needle core biopsies from 28 patients with PIN and 41 patients with adenocarcinoma. Neoplastic glands and those with PIN were analyzed on high power field (400x) and classified in three groups according to the extent of clefting. Immunohistochemical staining was performed following Microwave Streptavidin ImmunoPeroxidase (MSIP) protocol on DAKO TechMate Horizon automated immunostainer. Periacinar retraction clefting was significantly more prominent in prostatic carcinoma compared to PIN (p<0.0001) and nonneoplastic glands (p<0.0001). There was no difference between normal glands and PIN regarding clefting (p=0.8064). p63 was positive around the whole circumference in 12 out of 28 cases with PIN, and discontinuously positive in remaining 16 PIN cases suggesting initial disruption of the basal cell layer. p63 immunostaining was also positive in all nonneoplastic glands, and negative in all carcinomas. We conclude that retraction clefting was associated with cancer and lack of basal cells, but not with PIN. The relationship between clefting and p63 immunostaining in prostatic cancer should be further analyzed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17189982     DOI: 10.1007/bf02893413

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  22 in total

1.  Association of p63 with proliferative potential in normal and neoplastic human keratinocytes.

Authors:  R Parsa; A Yang; F McKeon; H Green
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

2.  Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.

Authors:  Michael H Weinstein; Sabina Signoretti; Massimo Loda
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

3.  Carcinoma of the prostate. A survey of 5,000 autopsies.

Authors:  B HALPERT; E E SHEEHAN; W R SCHMALHORST; R SCOTT
Journal:  Cancer       Date:  1963-06       Impact factor: 6.860

4.  Correlation of periacinar retraction clefting in needle core biopsies and corresponding prostatectomy specimens of patients with prostatic adenocarcinoma.

Authors:  Bozo Kruslin; Davor Tomas; Hermann Rogatsch; Ante Reljić; Majda Vucić; Drinko Balicević; Mladen Belicza; Gregor Mikuz
Journal:  Int J Surg Pathol       Date:  2005-01       Impact factor: 1.271

5.  Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens.

Authors:  H Rogatsch; P Moser; H Volgger; W Horninger; G Bartsch; G Mikuz; T Mairinger
Journal:  Hum Pathol       Date:  2000-09       Impact factor: 3.466

6.  Minimal focus of adenocarcinoma on prostate biopsy: clinicopathological correlations.

Authors:  X Leroy; S Aubert; A Villers; C Ballereau; D Augusto; B Gosselin
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

7.  Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.

Authors:  Ming Zhou; Rajal Shah; Ronglai Shen; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

8.  The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.

Authors:  Davor Tomas; Bozo Kruslin
Journal:  Prostate       Date:  2004-12-01       Impact factor: 4.104

Review 9.  Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy.

Authors:  Jonathan I Epstein
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

10.  Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact?

Authors:  Bozo Kruslin; Davor Tomas; Hermann Rogatsch; Irena Novosel; Hrvoje Cupić; Mladen Belicza; Ognjen Kraus; Gregor Mikuz
Journal:  Virchows Arch       Date:  2003-07-24       Impact factor: 4.064

View more
  6 in total

1.  High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.

Authors:  Tihana Džombeta; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2017-07-27       Impact factor: 3.201

2.  Periacinar retraction clefting in nonneoplastic and neoplastic prostatic glands: artifact or molecular involvement.

Authors:  Wagner José Fávaro; Amanda Cia Hetzl; Leonardo Oliveira Reis; Ubirajara Ferreira; Athanase Billis; Valéria Helena A Cagnon
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

3.  Periacinar retraction clefting and d2-40 expression in prostatic adenocarcinoma.

Authors:  Monika Ulamec; Tihana Džombeta; Hrvoje Cupić; Tanja Leniček; Davor Tomas; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2011-09-13       Impact factor: 3.201

4.  Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocarcinoma.

Authors:  Monika Ulamec; Davor Tomas; Christian Ensinger; Hrvoje Cupic; Mladen Belicza; Gregor Mikuz; Bozo Kruslin
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

5.  Peritumoral retraction clefting correlates with advanced stage squamous cell carcinoma of the esophagus.

Authors:  Tatjana Bujas; Ivana Pavić; Tanja Lenicek; August Mijić; Bozo Kruslin; Davor Tomas
Journal:  Pathol Oncol Res       Date:  2008-04-16       Impact factor: 3.201

6.  The Prognostic Value of Retraction Clefts in Chinese Invasive Breast Cancer Patients.

Authors:  Liangliang Huang; Yujie Li; Jun Du; Heng Li; Mengmeng Lu; Yuting Wang; Wenchao Zhou; Wei Wang; Haibo Wu
Journal:  Pathol Oncol Res       Date:  2021-04-21       Impact factor: 3.201

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.